Recommendations and Conclusions
(a) When microscopic nuclear cross sections are needed for calculations of radiation transport and energy deposition, for fast neutron and proton radiation therapy or radiation protection studies, the evaluated cross sections presented in this Report are recommended for use.
Reasons for this recommendation are as follows: (i) The evaluated cross section data provide uniquely comprehensive information on the emission spectra for light (A::;; 4) ejectiles, recoil (A > 4) spectra, and elastic scattering angular distributions. (ii) The evaluation methods employed in this Report emphasize the need to accurately model energy deposition as well as transport-most previous cross section evaluations were developed primarily for transport applications. (iii) The evaluated cross sections have been benchmarked against both experimental cross section data, and integral measurements of radiation transport and energy deposition (kerma coefficients), and shown to be generally in good agreement with the measurements. Applications in radiation therapy include the calculation of the three-dimensional distribution of absorbed dose in a patient, and the influence of beam-shaping techniques. Applications in radiation protection include the calculation of protection quantities (organ doses, effective dose) and operational quantities (dose equivalent), and of the response of dosimeters and spectrometers. (b) For evaluating the removal of protons from a proton therapy beam due to nonelastic nuclear reactions, the total nonelastic cross sections tabulated in Table D . l in Appendix D of this Report are recommended for use. (c) For studies that utilize PET to locate a proton therapy beam in real time, the results for radionuclide production cross sections from nuclear reactions, as tabulated on the ENDFeasy files on the accompanying CD, can be used. However, while the calculated results presented for radionuclide production exhibit reasonably good agreement with measurements, an evaluation of these cross sections that is based on experimental data, in addition to calculations, would be preferable for such studies. Such work, coordinated by the IAEA (IAEA, 1997) , is in progress. (d) Use of the total and partial kerma coefficients tabulated in Appendix C of this Report, for both individual isotopes and for mixtures and compounds , is recommended for dosimetry studies. These coefficients have been derived from the microscopic evaluated cross sections, and shown to be consistent with the existing experimental kerma coefficient database. Furthermore, the microscopic evaluated cross sections from which they were derived were also shown to be in good agreement with experimental measurements. (e) The average ICRU muscle-to-A150 plastic kerma ratio can be determined in a given neutron energy spectrum by convolving the energy-dependent kerma coefficient values shown in Tables C.2 and C.3 in Appendix C with the neutron energy spectrum under consideration. When this is done for three clinical neutron therapy p(66) + Be beams and a d(48.5) + Be beam, and the results averaged, a value of0.94 ~ 0.03 is obtained. (f) The light particle and heavy particle (recoil) ejectile energy spectra tabulations provided in the ENDF-easy files on the accompanying CD (see the example shown in Table D .3 in Appendix D) could contribute to an interpretation of the radiation quality of neutron and proton therapy beams.
